I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| classical monocyte | 25 studies | 31% ± 15% | |
| conventional dendritic cell | 23 studies | 31% ± 17% | |
| non-classical monocyte | 23 studies | 41% ± 19% | |
| macrophage | 21 studies | 31% ± 11% | |
| monocyte | 14 studies | 34% ± 11% | |
| dendritic cell | 12 studies | 33% ± 13% | |
| microglial cell | 12 studies | 37% ± 16% | |
| myeloid cell | 11 studies | 42% ± 18% | |
| CD16-negative, CD56-bright natural killer cell, human | 10 studies | 34% ± 20% | |
| mast cell | 9 studies | 22% ± 11% | |
| neutrophil | 9 studies | 32% ± 10% | |
| natural killer cell | 8 studies | 25% ± 11% | |
| CD16-positive, CD56-dim natural killer cell, human | 7 studies | 28% ± 9% | |
| alveolar macrophage | 6 studies | 33% ± 11% | |
| mononuclear phagocyte | 4 studies | 29% ± 11% | |
| B cell | 3 studies | 17% ± 2% | |
| leukocyte | 3 studies | 32% ± 17% |
